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Abstract
Background: Recently we and others have identified CD8 and CD4 T cell epitopes within the highly expressed M.
tuberculosis protein TB10.4. This has enabled, for the first time, a comparative study of the dynamics and function of CD4
and CD8 T cells specific for epitopes within the same protein in various stages of TB infection.
Methods and Findings: We focused on T cells directed to two epitopes in TB10.4; the MHC class I restricted epitope TB10.4
3–11 (CD8/10.4 T cells) and the MHC class II restricted epitope TB10.4 74–88 (CD4/10.4 T cells). CD4/10.4 and CD8/10.4 T cells
displayed marked differences in terms of expansion and contraction in a mouse TB model. CD4/10.4 T cells dominated in the
early phase of infection whereas CD8/10.4 T cells were expanded after week 16 and reached 5–8 fold higher numbers in the
late phase of infection. In the early phase of infection both CD4/10.4 and CD8/10.4 T cells were characterized by 20–25%
polyfunctional cells (IL-2
+, IFN-c
+, TNF-a
+), but whereas the majority of CD4/10.4 T cells were maintained as polyfunctional T
cells throughout infection, CD8/10.4 T cells differentiated almost exclusively into effector cells (IFN-c
+, TNF-a
+). Both CD4/
10.4 and CD8/10.4 T cells exhibited cytotoxicity in vivo in the early phase of infection, but whereas CD4/10.4 cell mediated
cytotoxicity waned during the infection, CD8/10.4 T cells exhibited increasing cytotoxic potential throughout the infection.
Conclusions/Significance: Our results show that CD4 and CD8 T cells directed to epitopes in the same antigen differ both in
their kinetics and functional characteristics throughout an infection with M. tuberculosis. In addition, the observed strong
expansion of CD8 T cells in the late stages of infection could have implications for the development of post exposure
vaccines against latent TB.
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Introduction
Mycobacterium tuberculosis (M.tb) continues to be a major threat to
global health and immense efforts are currently invested in an
attempt to understand the immune mechanisms involved in
controlling this chronic disease. CD4 T cells are induced early
during the acute phase whereas CD8 T cells have been reported to
expand in the later stages of the infection [1,2]. However, the
study of the dynamic development of antigen specific T cells at the
clonal level has been complicated by the fact that CD8 T cell
epitopes have only recently been identified within M.tb antigens.
Therefore, examining the involvement of CD8 T cells in the
defense against an infection with M.tb has in large part been based
on the study of bulk CD8 T cells as in the study performed by
Lazarevic et al. [1]. Recent studies have identified new CD8 T cell
epitopes within M.tb derived proteins, such as CFP-10 and TB10.4
[3–8]. TB10.4 is a low molecular mass protein that belongs to the
ESAT-6 family and was found to be highly immunogenic and to
confer protection against an aerosol challenge with M.tb when
administered to mice in a subunit vaccine composed of either
TB10.4 alone or TB10.4 fused to another immune dominant M.tb
protein, Ag85B [9,10]. Several T cell epitopes have been identified
within TB10.4, namely the MHC class I restricted epitopes; the
H2-K
b TB10.4 3–11, H2-K
d TB10.4 20–28 and the MHC class II
restricted epitope H2-K
d TB10.4 74–88 [3,4,11,12].
With the recently emerging novel information on CD4 and
CD8 T cells within the TB10.4 antigen it has now become possible
to study the dynamics of the emergence, expansion and
contraction of CD4 and CD8 T cell populations directed to
epitopes derived from the same M.tb protein. This represents a
unique opportunity to study the dynamic development of these
subsets without the interference imposed by a temporal shift in the
expression of different M.tb proteins during the course of a TB
infection. In the present study we therefore focused on T cells
directed against the two identified epitopes in TB10.4; the MHC-
class I restricted H2-K
b TB10.4 3–11 CD8 epitope [3] and the
MHC class II restricted H2-K
d TB10.4 74–88 CD4 epitope [11]. As
these epitopes are restricted to different haplotypes we used the
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5928CB6F1 hybrid (BALB/c6C57BL/6) which enabled us to study
both T cell populations in one mouse strain in terms of dynamics
as well as functional and phenotypic changes during a persistent
M.tb infection. We found that the dynamics of expansion,
contraction and functional characteristics differed markedly for
CD8/10.4 and CD4/10.4 T cells throughout a TB aerosol
infection.
Results
The dynamic development of CD4 and CD8 responses to
TB10.4 during TB infection
Anti-TB10.4 3–11 CD8 T cells and anti-TB10.4 74–88 CD4 T
cells (hereafter called CD8/10.4 and CD4/10.4 cells) represent a
significant proportion of the T cells induced by infection with M.tb
[3]. To study and compare the dynamic development of these T
cells, CB6F1 (BALB/c6C57BL/6) mice were infected by the
aerosol route with M.tb Erdman and the T cell immune response
against TB10.4 74–88 and TB10.4 3–11 was analyzed at different
time points following infection. Epitope recognition was assessed
using TB10.4 74–88 and TB10.4 3–11 peptides for in vitro
stimulation of lymphocytes from infected mice and the frequency
of CD4/10.4 or CD8/10.4 T cells out of all T cells following
6 hour stimulation with antigen was analyzed by flow cytometry
(calculation shown in materials and methods) (Fig. 1). The CFU
levels in the lung showed an increase up to week 4–5 post infection
where after the CFU levels did not change significantly throughout
the course of infection (Fig. 2). In terms of the CD4/10.4 and
CD8/10.4 cells the dynamic development of priming, expansion
and contraction of these cells followed different patterns (Fig. 3). In
the spleen and blood, both CD4/10.4 and CD8/10.4 cells could
be detected, but the frequencies out of all lymphocytes, were
around 1%, and not as high as seen in the lung. In the lungs,
CD4/10.4 cells expanded rapidly and reached around 3% of all T
cells (5.5% of all CD4 T cells, data not shown) 4–6 weeks after
infection, which represented a significant increase in CD4/10.4
cell numbers compared to week 0 post infection (student’s T test,
p,0.05). The percentage then declined to approximately 1.5% of
all T cells and it stayed at that level for the rest of the experiment
(until week 43) (Fig. 3A). In contrast, CD8/10.4 displayed a
delayed kinetic and this T cell population reached its initial peak as
late as week 15 post-infection where 6.5% of all T cells (and 18%
of all CD8 T cells, data not shown) recognized this epitope. This
was followed by a contraction from week 22–27 (to around 2%)
after which CD8/10.4 cells again stabilized at a level between 5–
6% of all T cells (and 18% of all CD8 T cells, data not shown)
(Fig. 3B). The accelerated expansion of CD4/10.4 was confirmed
by ELISPOT at week 6 where TB10.4 74–88 stimulation induced
up to 7 fold more spot forming (CD4/10.4) cells than stimulation
with the CD8 epitope TB10.4 3–11 (data not shown). Staining the
cells with the H-2K
b/TB10.4 pentamer that specifically identified
CD8/10.4 cells, confirmed the kinetic pattern observed after
peptide stimulation (Fig. 3C) and the similar percentages obtained
by pentamer and IFN-c staining indicated that this CD8 T cell
population expressed IFN-c throughout the observation period.
Thus, following infection the frequency of CD4 and CD8 T cells
specific for epitopes both encoded within the TB10.4 molecule,
followed distinct patterns.
Activation state of CD8/10.4 and CD4/10.4 T cells
throughout infection
To characterize the phenotype of CD8/10.4 and CD4/10.4 T
cells, cells isolated from the lungs during infection were stimulated
in vitro with TB10.4 74–88 and TB10.4 3–11 and analyzed by flow
cytometry for expression of CD4, CD8, CD44, CD11a and IFN-c.
Based on the dynamic changes in the size of the CD8/10.4 and
CD4/10.4 T cells (Fig. 3), we compared the phenotype of the
epitope specific cells during the different stages of the infection i.e.
the early stage (week 6) and the late stage (week 40). At both time
points the majority of the IFN-c producing CD4 and CD8 T cells
were CD44
high and thus resembled a typical effector phenotype.
The same cells also expressed low levels of CD45RB and CD62L
confirming their effector phenotype, and at other time points
throughout the infection this staining profile did not change (data
not shown). The expression of these markers was not significantly
changed during the in vitro stimulation itself (data not shown). As
the percentages indicated in the figure are out of the CD8 or CD4
T cell population, they are higher compared to the percentages in
figure 3 which are out of the total number of T cells. As expected,
both the CD8/10.4 and CD4/10.4 T cells expressed CD11a
which has been shown to be an important homing marker to the
lungs for T cells during an infection with M.tb [13]. Thus, both
CD4/10.4 and CD8/10.4 T cells displayed an effector phenotype
and no significant phenotypic changes, based on these surface
markers, were seen for the two T cell populations over the course
of the infection (Fig. 4).
Cytokine expression by CD8/10.4 and CD4/10.4 T cells
throughout infection
We next looked at the co-expression of multiple cytokines in
CD8/10.4 and CD4/10.4 T cells. Cells from infected lungs, taken
at week 6 or week 43 post infection, were stimulated with
TB10.4 3–11 or TB10.4 74–88 prior to staining with anti-CD4,
-CD8, -IFN-c, -TNF-a and –IL-2. The results showed that TNF-
a/IFN-c effector cells constituted the major population observed
among both CD4 and CD8/10.4 T cells (Fig. 5A–C), reflecting an
ongoing stimulation in the M.tb infected animals, and in
agreement with the results shown in figure 4. However, in terms
of polyfunctionality, i.e. the co-expression of multiple cytokines
such as TNF-a, IFN-c and IL-2, we observed a difference between
the two T cell populations as the infection progressed. Thus, at the
late time point there was still a significant proportion of the CD4/
10.4 cells that were polyfunctional in contrast to the CD8/10.4
cells (Fig. 5B and C). For the CD8/10.4 T cell population the
proportion of TNF-a, IFN-c and IL-2 co-expressing cells
decreased from around 25% during the early timepoint to 0.5%
during the late timepoint. However, the proportion of polyfunc-
tional CD4/10.4 T cells did not change significantly despite the
ongoing infection (Fig. 5D). Taken together, these results showed
that in contrast to the CD8/10.4 T cells, a considerable
proportion of the CD4/10.4 T cells were maintained as
polyfunctional T cells.
Cytotoxic potential of CD8/10.4 and CD4/10.4 T cells
throughout infection
We also compared the functional capabilities of the CD4/10.4
and CD8/10.4 cells in terms of cytotoxicity. We first investigated
CD107a/b, which is a known marker for degranulation. A clear
change over time in the expression of CD107a/b was observed.
On CD8/10.4 T cells expression of CD107a/b increased up to
,70% during the intermediate and late chronic phase (Fig. 6A). In
contrast, we found only a minor increase in the percentage of
CD4/10.4 IFN-c
+ CD107a/b
+ cells during the infection (Fig. 6B).
This difference in CD107a/b expression was also reflected in the
CD107a/b MFI which showed a higher increase on CD8/10.4
IFN-c
+ T cells than on CD4/10.4 IFN-c
+ T cells as the infection
progressed (Fig. 6C). As these results indicated an increased
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infection, we also compared the in vivo capability of CD8/10.4
and CD4/10.4 T cells to eliminate target cells presenting the
specific epitope in infected mice throughout infection. We used the
in vivo cytotoxicity assay where CFSE labeled splenocytes from
naı ¨ve mice, unpulsed or pulsed with either TB10.4 3–11 or
TB10.4 74–88 were adoptively transferred into infected mice.
Thereafter, peptide specific lysis of the transferred cells was
investigated by flow cytometric analysis of infected recipient lung
cells. In the early phase of the infection we observed approx-
imately 30% specific killing of both TB10.4 3–11 or TB10.4 74–88
loaded target cells, demonstrating that both CD8/10.4 and CD4/
10.4 T cells possessed cytotoxic potential (Fig. 6D). However, in
the later phase of the infection, and in particular during the late
Figure 1. The TB10.4 CD4 and CD8 T cells epitopes that are recognized by CB6F1 mice (BALB/c6C57BL/6). (A) the amino acid sequence
of the TB10.4 protein with the CD4 and CD8 T cell epitopes underlined. (B) Lung lymphocytes from mice infected at week six after aerosol infection
were stimulated in vitro with either the TB10.4 3–11 (QIMYNYPAM) or the TB10.4 74–88 (THEANTMAMMARDT) for 6 hours before being assessed for IFN-
c production by flow cytometry. A gating sequence was applied to the data to determine the frequencies of IFN-c positive CD4 and CD8 T cells. The
rationale for the FSC-H vs. FSC-A gating is to capture only singlet particles and eliminate doublets that may occur as a result of e.g. cells sticking
together.
doi:10.1371/journal.pone.0005928.g001
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pulsed target cells was observed indicating a qualitative change of
the CD8/10.4 T cells over time (Fig. 6D). In contrast to the
increased cytotoxic potential of CD8/10.4 T cells over time,
CD4/10.4 T cells initially exhibited cytolytic activity (24%
specific killing) that however decreased to 7% at the late chronic
stage (Fig. 6D). Thus, both in terms of both polyfunctionality and
cytoxicity CD4/10.4 and CD8/10.4 T cells showed marked
differences.
Discussion
Numerous reports have focused on the characterization of T
cells primed during infection with M.tb. The majority of these
studies have been based on the description of bulk T cells and has
not addressed the characteristics of single epitope specific T cells
[1,14,15]. However recently, due to the discovery of new M.tb T
cell epitopes, a number of laboratories have focused on the
characterization of single T cell clones elicited following an
infection. Thus, a report on tracking M.tb72F epitope specific
CD8 T cells induced after infection showed that the CD8 T cells
were present in significant numbers over the course the infection
and that the CD8 T cells appeared to change from an effector
phenotype to a more T cell memory-like phenotype [6]. Other
laboratories have identified M.tb induced CD8 T cells specific for
either TB10.4 or CFP10 in the C57BL/6 and BALB/c mouse
model and demonstrated that they exhibit cytolytic activity [3,5].
However, only recently have both class I and II restricted epitopes
within the same antigen been identified thereby enabling a study
of the emergence, expansion and contraction of specific CD4 and
CD8 T cells during the course of a TB infection without the
interference imposed by a potential temporal shift in the
expression of different M.tb antigens during the course of a TB
infection.
In the present study we provided a functional and phenotypical
characterization of TB10.4 epitope specific CD4 and CD8 T cells
during a long term chronic infection. TB10.4 is part of the ESAT-
6 family of proteins and is highly expressed throughout an
infection with M.tb [10,16]. We focused on the TB10.4 CD4
epitope THEANTMAMMARDT (TB10.4 74–88) and the CD8
epitope QIMYNYPAM (TB10.4 3–11). These epitopes have been
shown to elicit strong responses leading to high numbers of
TB10.4 3–11 specific CD8 T cells in C57BL/6 or TB10.4 74–88
specific CD4 T cells in BALB/c mice [3,11,17].
Figure 2. The bacterial load in the lungs throughout infection
shown as Log10 CFU. Mice were challenged by the aerosol route
with virulent M. tuberculosis. At the indicated timepoints 3–6 mice were
killed and the bacterial burden (CFU) was measured in the lung.
doi:10.1371/journal.pone.0005928.g002
Figure 3. The kinetics of CD4/10.4 and CD8/10.4 following aerosol infection with M.tb. (A and B) CB6F1 mice were infected by the aerosol
route with virulent M.tb Erdman and lymphocytes were obtained from lungs or blood and then stimulated with TB10.4 3–11 or TB10.4 74–88 for
assessment of IFN-c production by FACS analysis. Frequencies represent IFN-c production out of total T cells. Background staining from cells
stimulated with medium alone has been deducted (Background ,0.5%). Each time point represents the mean from at least three individual
mice6standard error of the mean (SEM). (C) Lung or blood cells were stained directly ex vivo with H2-K
b pentamer loaded with IMYNYPAM.
Background staining from naı ¨ve mice has been deducted. Each time point consists of data from a pool of 3–6 mice. (**p,0.01, Student’s t-test).
doi:10.1371/journal.pone.0005928.g003
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induced substantial amounts of TB10.4 specific CD8 and CD4 T
cells in the lungs. This was observed after measuring IFN-c
positive T cells following in vitro stimulation with the epitopes or
after staining the CD8 T cells ex vivo with the H2-K
b pentamer
(Fig. 1 and 3). In the acute phase of infection (,6 weeks) the CD4/
10.4 T cells were recruited and expanded at the site of infection in
an accelerated fashion (Fig. 3) that resulted in 2–9 times more
CD4/10.4 T cells at week 6 of infection (measured by FACS or
ELISPOT, (fig. 3, and data not shown). In the later stages of
infection CD4/10.4 T cells were maintained at constant levels and
accounted for 1–3% of the total T cell population throughout
infection (up till 43 weeks after infection, Fig. 3). CD8/10.4 cells
for comparison were greatly expanded in the later stages of
infection (week 16 and 35), in agreement with a previous study
conducted on bulk CD8 T cells [1]. Thus, following the initial
acute phase we observed an increase in the frequency of CD8/
10.4 T cells from week 16 to week 20 where up to 6.5–9% of all T
cells were specific for TB10.4 3–11 (Fig. 3B and C). Thereafter, we
observed a decline in the number of CD8/10.4 cells to between 2
and 4% between week 22–27 post infection. This was followed by
an increase in numbers with levels above 5% post week 35 of
infection (Fig. 3B and C). It is interesting that the major expansion
of CD8 T cells occurred in the later stages of infection. This
implies that these cells may serve an important role at this stage of
infection, which could have implications for the development of
post exposure vaccines against latent TB. Indeed, previous
experiment in a mouse model for latent TB showed that depleting
of CD8 T cells led to reactivation of latent TB [18].
It has been suggested that such a dynamic behavior could reflect
the fluctuating responsiveness of the immune system to the
periodic and transient bursts of mycobacterial replication inside
infected lungs and a fine-tuning of the response to control the
infection without inducing substantial pathology [1]. A recent
study suggested that this dynamic fluctuation of T cell numbers
occurred simultaneously for both subsets, but studied the dynamics
of the overall T cell subsets and not T cells at an antigen specific
level [1]. In contrast, our study was based on the tracking of
epitope specific CD4 and CD8 T cells, and we observed a clear
difference in the frequencies of the TB10.4 specific CD8 and CD4
T cells (Fig. 3), in that CD4/10.4 dominated the early stages and
CD8/10.4 cells the intermediate and late stages. It could be
speculated that in the early stages the bacteria are primarily taken
up by professional APC’s and via the phagosomes directed to the
MHC-II processing pathway leading to a preferential priming of
CD4 T cells. It is however important in this context to emphasize
that the difference we observe is a difference in quantity and
kinetics and does not reflect a complete lack of MHC-I
presentation as we also find detectable levels of CD8/10.4 T cells
in the early phase of infection although at a lower level than CD4/
10.4 T cells. However, in the later stages of infection (.15 weeks),
a change in the processing of antigen occurs that favor
presentation on MHC-I and expansion of CD8/10.4. This change
could involve increased transfer of antigen from phagosomes into
the MHC class I pathway in heavily infected DCs [19,20] or
increased apoptosis of antigen loaded macrophages and release of
antigen material or mycobacteria for subsequent uptake and cross-
priming in either CD8
+ DC’s [21] or neutrophils [19,20,22].
Figure 4. Phenotypic analysis of CD4/10.4 and CD8/10.4 during a persistent infection. Lung lymphocytes from mice sacrificed at different
stages of infection (Early: week 6; late: week 40) were stimulated with (A) TB10.4 3–11 or (B) TB10.4 74–88 prior to staining for the surface markers CD44,
CD11a and intracellularly for IFN-c. Samples were then examined by flow cytometry. FACS plots are shown for one mouse, representative of 3–4 mice.
doi:10.1371/journal.pone.0005928.g004
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been demonstrated to be a very efficient source of cross-priming in
vivo and are abundant in TB granulomas in the late or chronic
phase of infection [22,23]. Finally, as the bacterial numbers
increase, infection of non-APC’s, that primarily present antigens
on MHC-I, may also increase and thus favor expansion of CD8 T
cell numbers. Such cells could be the epithelial cells, which have
indeed been shown to be infected by M.tb during a chronic
infection [24].
A few other recent studies have reported tracking of specific
CD8 T cells. Thus, as mentioned above, in a recent study using a
class I tetramer reagent to track M.tb72F antigen-specific CD8 T
cells (GAPINSATAM) in the lungs of infected mice up to day 100
post infection, a different and less dynamic kinetic pattern was
observed. The frequency of GAPINSATAM specific CD8 T cells
gradually increased up till day 30 post infection (,week 4) and
then declined until day 100 (,week 14) [6]. It may be that the
different findings from this study, compared to our results, relate to
a differential antigenic expression of the mycobacterial proteins
TB10.4 and M.tb72F or the processing of the epitopes
QIMYNYPAM and GAPINSATAM. Other long term studies of
T cell populations have been performed recently in our and other
laboratories. Thus, Billeskov et al. demonstrated that TB10.4 3–11
specific CD8 T cells comprised a large part of the CD8 T cell
population in the lungs of infected C57BL/6 mice at 50 weeks post
infection [3] and Kamath et al. showed that at 32 weeks post
infection there was approximately 16% TB10.4 20–28 specific CD8
T cells in the lungs of infected BALB/c mice [5]. However, as
these studies did not, to the same degree as the present study,
include a kinetic analysis of both CD4 and CD8 T cells specific for
the same protein, the main conclusions were that TB10.4 or
CFP10 CD8 T cells dominate in the late phases of infection, and a
distinct kinetic pattern that differed from that of the CD4 T cells
against the same protein, was not described.
Throughout the infection all TB10.4 3–11 and TB10.4 74.88
epitope specific CD8 and CD4 T cells displayed an effector
phenotype in agreement with a previous study which also showed
that both CD4 and CD8 T cell bulk populations in the lungs of
chronically infected mice expressed a cell surface phenotype
consistent with that of effector T cells (Fig. 4 and [25]). All IFN-c
+
Figure 5. Changes in cytokine profiles of CD4/10.4 and CD8/10.4 T cells during a chronic infection. Cells from infected lungs were
stimulated with TB10.4 3–11 or TB10.4 74–88 prior to staining with anti-CD4, -CD8, -IFN-c, -TNF-a and –IL-2. (A) Cytokine profiles of CD4/10.4 was
determined by first dividing the CD4 T cells into IFN-c positive (+) or IFN-c negative (2) cells. Both the IFN-c+ and IFN-c- cells were analyzed with
respect to the production of TNF-a and IL-2. The numbers in the quadrant gates of the plots denominates each distinct population based on their
cytokine production and is color coded as shown. To illustrate the gating sequence two examples from a late infection stage are shown. (B and C).
The pie-charts illustrate the relative contribution of the different cytokine T cell populations to the total CD4/10.4 population and data is depicted for
both an early and a late time point, for 3 mice at each time point. Background (.0.5%) has been deducted. (D) The proportion of IFN-c
+ TNF-a
+ IL-2
+
within the CD4/10.4 or CD8/10.4 T cells populations in the early stage compared to the late stage of infection.
doi:10.1371/journal.pone.0005928.g005
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particular integrin as confirmed by the increased susceptibility to
aerosol M.tb infection in CD11a gene knockout mice [13].
Comparing the expression of TNF-a, IFN-c and IL-2 among
CD4/10.4 and CD8/10.4 T cells at an early and late time point
showed that whereas both populations contained polyfunctional T
cells at early stages of infection, only CD4/10.4 maintained a
substantial part of the cell population as polyfunctional T cells
(Fig. 5A–C). In contrast, CD8/10.4 T cells all developed into
terminally differentiated effector cells which is in agreement with
the observations from persistent viral infections where chronicity is
associated with exhaustion, loss of both CD8 function and
polyfunctionality [26,27]. Interestingly, the presence of polyfunc-
tional T cells have been shown to correlate with protective
immunity against infections such as Leishmania major, and to form
the basis for a long lived memory response [28], indicating that
this subset of T cells may also be important for the protection
against infection with M.tb, or reactivation of latent TB. CD4/10.4
and CD8/10.4 also differed in terms of cytotoxicity. We first
looked at the degranulation marker CD107a/b which have been
demonstrated to correlate with cytotoxicity [29,30]. During the
acute phase, 30% of the TB10.4 3–11 specific CD8 T cells
expressed CD107a/b as opposed to the ,10% expressed by the
TB10.4 74–88 specific CD4 T cells. As the disease progressed no
significant increase in CD107a/b expression was observed within
the TB10.4 74–88 specific CD4 T cell population in contrast to the
TB10.4 3–11 specific CD8 T cells where the numbers increased to
approximately 70% of all IFN-c producing TB10.4 3–11 cells
(17.2%/(17.2%+8.27%), see also figure 6) indicating that these
cells were potentially more cytotoxic (Fig. 6). The ability of the
TB10.4 specific CD8 T cell to perform cytolysis of peptide pulsed
target cells in vivo was indeed confirmed in the in vivo cytotoxicity
assay where the killing of TB10.4 3–11 pulsed target cells increased
with time in contrast to the killing of TB10.4 74–88 pulsed target
cells which decreased with time (Fig. 6D). Interestingly, during the
early and intermediate phase of infection CD4/10.4 displayed
significant cytolytic activity, despite only a minor expression of
CD107a/b. This indicated that CD4/10.4 T cells may exert their
cytotoxic capabilities through other pathways besides degranula-
tion, such as the Fas/FasL pathway [31]. However, at later stages
of the infection CD4/10.4 cells gradually lost this cytotoxic
function in contrast to the CD8/10.4 cells.
Inconclusion, this studyshowsthat CD4andCD8T cellsspecific
for epitopes on the same M.tb antigen display markedly different
dynamic patterns in terms of expansion, contraction and functional
properties throughout an M.tb infection. Our results also indicate
that whereas the function of CD4/10.4 and CD8/10.4 cells may be
partially overlapping in the early stages of infection (judged by the
small differences in polyfunctionality, CD107a/b expression, and in
vivo cytoxicity), at later time points these cells showed significant
differences in these markers suggesting more disparate effector
functions of the subsets in the late stages of infection.
Figure 6. Functional characterization of the CD4/10.4 and CD8/10.4 T cells at different stages of infection. (Early: week 6; Intermediate:
week 16, late: week 40) (A and B) Lung cells from infected mice were stimulated in vitro with TB10.4 3–11 or TB10.4 74–88 (lower panel) or left non
stimulated (‘‘Media’’, upper panel) in the presence of aCD107a/b and stained with aIFN-c and aCD8 (A), or aCD4 (B), antibodies (C) CD107a/b MFI of
the IFN-c positive cells following in vitro stimulation with TB10.4 3–11 or TB10.4 74–88. (D) The specific lysis of TB10.4 3–11 or TB10.4 74–88 loaded cells
was determined in an in vivo cytotoxicity assay. Unloaded splenocytes (CFSE
low) and TB10.4 3–11 or TB10.4 74–88 loaded splenocytes (CFSE
high) from
naı ¨ve mice were transferred into infected mice. The amount of splenocytes killed in vivo by cytotoxic T cells specific for either TB10.4 3–11 or
TB10.4 74–88 was observed as a reduction in the CFSE
high population and a percent specific lysis was calculated. A value of P,0.05 (students paired t-
test) was considered significant and is shown by *.
doi:10.1371/journal.pone.0005928.g006
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Animal handling
Studies were performed with 6–8-week-old female CB6F1
(BALB/c6C57BL/6) from Harland Netherlands. Non-infected
mice were housed in cages in appropriate animal facilities at Statens
Serum Institut. Infected animals were housed in cages contained
within laminar flow safety enclosures (Scantainer from Scanbur,
Denmark) in a separate biosafety level 3 facility. All mice were fed
radiation sterilized 2016 Global Rodent Maintenance diet (Harlan,
Scandinavia) and water ad libitum. All animals were allowed a 1-
week rest period after delivery before the initiation of the
experiments. The handling of mice were conducted in accordance
with the regulations set forward by the Danish Ministry of Justice
and animal protection committees by Danish Animal Experiments
Inspectorate permit 2004-561-868 of 01-07-2004. This was in
compliance with European Community Directive 86/609 and the
U.S. Association for Laboratory Animal Care recommendations for
the care and use of laboratory animals. All animal handling was
done at Statens Serum Institut by authorized personnel.
Bacteria
M. tuberculosis Erdman was grown at 37uC in suspension in
Sauton medium (BD Pharmingen) enriched with 0.5% sodium
pyruvate 0.5% glucose 0.2% Tween 80. All bacteria were stored at
280uC in growth medium at ,5610
8 CFU/ml. Bacteria were
thawed, sonicated, washed and diluted in phosphate-buffered
saline (PBS). All bacterial work was performed at the Statens
Serum Institut by authorized personnel.
Antigens
Synthetic overlapping peptides (18-mers and 9-mers) covering
the complete primary structure of TB10.4 along with the TB10.4
peptides TB10.4 3–11 QIMYNYPAM and TB10.4 74–88
THEANTMAMMARDT were synthesized by standard solid-
phase methods on a SyRo peptide synthesizer (MultiSynTech,
New England) at the JPT Peptide Technologies (Berlin, Germany),
or at Schafer-N (Copenhagen, Denmark). Peptides were lyophi-
lized and stored dry at 220uC until reconstitution in PBS.
Experimental infections
Upon challenge by the aerosol route, the animals were infected
with either a low dose ,50 CFU or high dose ,100–150 CFU of
M.tb Erdman/mouse with an inhalation exposure system (Glas-Col,
Indiana,USA). The numbers of bacteria in the spleen or lung were
determined by serial 3-fold dilutions of individual whole-organ
homogenates in duplicate on 7H11 medium supplemented with
PANTA
TM (Becton Dickinson, San Diego, USA). Colonies were
counted after 2–3 wk of incubation at 37uC.
Lymphocyte cultures
Peripheral blood mononuclear cells (PBMCs) were purified on a
density gradient of mammal lympholyteH cell separation media
(Cedarlane Laboratories Inc., Canada). Splenocyte cultures were
obtained by passage of spleens through a metal mesh followed by
two washing procedures using RPMI. Lung lymphocytes were
obtained by passage of lungs through a 100 mm nylon cell strainer
(BD Pharmingen, USA) followed by two washing procedures using
RPMI. Cells in each experiment were cultured in sterile microtiter
wells (96-well plates; Nunc, Denmark) containing 2210610
5 cells
in 200 ml of RPMI 1640 supplemented with 1% (v/v) premixed
penicillin-streptomycin solution (Invitrogen Life Technologies),
1 mM glutamine, and 10% (v/v) fetal calve serum (FCS) at 37uC/
5% CO2.
Flow cytometric analysis
Intracellular cytokine staining procedure: Cells from blood,
spleen or lungs of mice were stimulated for 1–2 h with 2 mg/ml Ag
at 37uC and subsequently incubated for 5 h at 37uC with 10 mg/
ml brefeldin A (Sigma-Aldrich, Denmark) at 37uC. Fc receptors
were blocked with 0.5 mg/ml anti-CD16/CD32 mAb (BD
Pharmingen, USA) for 10 minutes, whereafter the cells were
washed in FACS buffer (PBS containing 0.1% sodium azide and
1% FCS) before staining with a combination of the following rat
anti-mouse antibodies PE-Cy7-, PerCP-Cy5.5-anti-CD8a (53-6.7,
RM4-5), APC-Cy7-anti-CD4 (GKI.5), FITC-, PE-Cy5.5-anti-
CD44 (IM7), FITC-anti-CD45RB (16A), PE-Cy5-anti-CD11a
(2D7), FITC-anti-CD107b (ABL-93), FITC-anti-CD107a (ID4B),
PE-, APC-anti-CD62L (MEL-14) all purchased from BD Phar-
mingen (San Diego, USA), R&D systems (Minneapolis, USA) or
eBiosciences (San Diego, USA). Cells were washed with FACS
buffer before fixation and permeabilization using the BD Cytofix/
Cytoperm
TM (BD, San Diego, CA, USA) according to the
manufacturer’s protocol before staining intracellularly with PE-,
PE-Cy7, APC-Anti-IFN-c (XMG1.2), PE-anti-TNFa, and/or PE-,
APC-anti-IL-2 (JES6-5H4). When FITC-anti-CD107b (ABL-93)
and FITC-anti-CD107a (ID4B) were used these were added to the
wells along with the antigens at the beginning of the incubation
period. Furthermore, a PE-conjugated Pro5H MHC-I (H-2K
b)
pentamer (Proimmune, England) loaded with the minimal CD8
epitope of TB10.4 was used. Due to technical issues, the MHC-I
molecules of the pentamer was loaded with TB10.4 4–11 instead of
TB10.4 3–11. After washing, cells were resuspended in formalde-
hyde solution 4% (w/v) pH 7.0 (Bie & Berntsen, Denmark) and
samples were analysed on a six-colour BD FACSCanto flow
cytometer (BD Biosciences, USA). Data analysis was done with
FACSDiva Software (Becton-Dickinson, San Diego, CA, USA)
and Flowjo Software ( Tree Star, Asland, OR, USA). To
calculate the %CD4/10.4 or CD8/10.4 T cells out of all
lymphocytes the following equation was used (shown here for
the CD4/10.4 T cells): %IFN-c
+ CD4 out of CD4 T
cells6((%CD4 T cells*/(%CD4 T cells*+%CD8 T cells*), *out
of all counted lymphocytes))6100%).
In vivo cytotoxicity assessed by adoptive transfer of
CFSE-labeled target cells
Single cell suspensions of CB6F1 spleens were obtained by
passage through a fine metal mesh filter. Erythrocytes were
depleted by lysis in ammonium chloride solution, washed in PBS
before resuspension in incomplete RPMI and stained with 5(6)-
Carboxyfluorescein diacetate N-succinimidyl ester (CFSE)(Sigma-
Aldrich, San Louis, USA) at CFSE
High (20 mM) or CFSE
Low
(2 mM) concentration for 10 min at 37u. Excess CFSE was
quenched with RPMI containing 10% FCS and subsequently
washed in medium without FCS. Next, CFSE
High labeled cells
were pulsed with TB10.4 3–11 or TB10.4 74–88 at a concentration
of 10 mg/ml of peptide for 1.5 hr at 37u. After being washed and
resuspended in PBS the CFSE
High and CFSE
Low suspensions for
each peptide was mixed at equal volumes. Final solutions of
20610
6 cells in a volume of 200 ml were given intravenously into
naı ¨ve and infected mice. 18 hrs later adoptively transferred mice
were sacrificed. Lungs were removed, homogenized and resus-
pended in formaldehyde before acquisition on a BD FACSCanto
flowcytometer (BD Biosciences, USA). To evaluate the frequency
of specific lysis, the ratio of CFSE
High and CFSE
Low of infected
mice were compared to naı ¨ve control mice and was calculated
using the formula (12(%CFSEhigh cells/%CFSElow cells)
6100%). For the infected and naı ¨ve groups 3 and 2 mice were
used respectively.
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